DNER and acute lymphoblastic leukemia: In a recent study performing Capture-C approach at over 60 loci to test the impact of BET inhibitors on enhancer–promoter interactions and transcriptional change in an acute lymphoblastic leukemia cell line, the authors found that BET inhibition has a strong effect on transcription but enhancer–promoter interactions remained undisrupted (48).